Literature DB >> 2183575

The human eosinophil in inflammation.

P Venge1.   

Abstract

Active research during recent years has clearly shown that the eosinophil is a potent inflammatory cell taking active part in almost all kinds of inflammatory processes. The activity of the human eosinophil is mediated by the secretion of four well characterized cytotoxic proteins, ECP, EPO, EPX/EDN and MBP in addition to lipid mediators such as LTC4 and PAF and toxic oxygen metabolites. The cytotoxic potential of the eosinophil has been demonstrated in a number of diseases with a close association of eosinophil accumulation with secretion of granule proteins and tissue injury. Also the measurements of the proteins in various body fluids have provided evidence for the active participation of eosinophils in a number of diseases such as asthma, ulcerative colitis, rheumatoid arthritis, psoriasis to mention a few. The identification of the principles that attract eosinophils to the sites of inflammation must be a major goal in our attempts to control the activity of this potents cell.

Entities:  

Mesh:

Year:  1990        PMID: 2183575     DOI: 10.1007/BF01964739

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  15 in total

1.  Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins.

Authors:  P Venge; A Strömberg; J H Braconier; L E Roxin; I Olsson
Journal:  Br J Haematol       Date:  1978-04       Impact factor: 6.998

2.  Mechanism of membrane damage mediated by human eosinophil cationic protein.

Authors:  J D Young; C G Peterson; P Venge; Z A Cohn
Journal:  Nature       Date:  1986 Jun 5-11       Impact factor: 49.962

3.  New method for the measurement of eosinophil migration.

Authors:  L Håkansson; D Westerlund; P Venge
Journal:  J Leukoc Biol       Date:  1987-12       Impact factor: 4.962

Review 4.  The eosinophilic leukocyte: structure and function.

Authors:  G J Gleich; C R Adolphson
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

5.  Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein.

Authors:  P C Tai; C J Spry; C Peterson; P Venge; I Olsson
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

6.  The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay.

Authors:  S J Ackerman; D A Loegering; G J Gleich
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

7.  Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein.

Authors:  T L Wasmoen; M P Bell; D A Loegering; G J Gleich; F G Prendergast; D J McKean
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

8.  Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique.

Authors:  A Egesten; J Alumets; C von Mecklenburg; M Palmegren; I Olsson
Journal:  J Histochem Cytochem       Date:  1986-11       Impact factor: 2.479

9.  Epithelial injury by human eosinophils.

Authors:  P Venge; R Dahl; K Fredens; C G Peterson
Journal:  Am Rev Respir Dis       Date:  1988-12

10.  The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X.

Authors:  K Fredens; R Dahl; P Venge
Journal:  J Allergy Clin Immunol       Date:  1982-11       Impact factor: 10.793

View more
  8 in total

1.  A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.

Authors:  N Cooper; M M Teixeira; J Warneck; J M Miotla; R E Wills; D M Macari; R W Gristwood; P G Hellewell
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Aspergillus antigen-induced eosinophil differentiation in a murine model.

Authors:  P S Murali; G Dai; A Kumar; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  An in vitro investigation of the anti-inflammatory properties of potassium humate.

Authors:  Gisela Käthe Jooné; Constance Elizabeth Jansen van Rensburg
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

4.  Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.

Authors:  M M Teixeira; A G Rossi; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

5.  Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.

Authors:  C Zuany-Amorim; D Leduc; B B Vargaftig; M Pretolani
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.

Authors:  E Coëffier; D Joseph; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 7.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages.

Authors:  X Tan; W Hsueh; F Gonzalez-Crussi
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.